Literature DB >> 1796056

Interspecies differences in the nasal absorption of insulin.

F W Merkus, J C Verhoef, S G Romeijn, N G Schipper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1796056     DOI： 10.1023/a:1015880502548

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  2 in total

1.  Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.

Authors:  M J Deurloo; W A Hermens; S G Romeyn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

2.  Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.

Authors:  F W Merkus; J C Verhoef; S G Romeijn; N G Schipper
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200
  2 in total
  5 in total

1.  The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

Authors:  L Illum; M Hinchcliffe; S S Davis
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 2.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.

Authors:  N G Schipper; S G Romeijn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 4.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

5.  Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Authors:  A M Dyer; M Hinchcliffe; P Watts; J Castile; I Jabbal-Gill; R Nankervis; A Smith; L Illum
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.